In the backdrop of the Supreme Court judgment against Novartis trying to seek patent on its anticancer drug Gleevec used for treatment of CML and the granting of license to pharmaceutical company Natco by the Controller General of Patents India… Continue Reading →
Anand Grover | Apr 2, 2013, After 2005 India started granting product patents on medicines. However, Section S ection 3(d), one of the safeguards introduced by Parliament, seeks to prevent patenting of new forms of known substances unless they exhibit enhanced efficacy…. Continue Reading →
Vidya Krishnan , livemint Court says Glivec does not meet any standard of ‘novelty or inventiveness’ to qualify for a patent First Published: Mon, Apr 01 2013. Shares of Novartis India fell as much as 7% after the Supreme Court judgement. The… Continue Reading →
HUNTED AT WORKPLACE, HOUNDED FOR PROTEST In a city where everyone strives to find their place under the sun, women face a double challenge — to excel in their professions and also fight off strong gender bias Swati Deshpande |… Continue Reading →
Add your voice today! We would like to encourage you to add your voices to the UN Special Rapporteur‘s report on access to medicines and the right to health. Your voices will significantly contribute to integrating women’s human rights and… Continue Reading →
© 2024 Kractivism — Powered by WordPress
Theme by Anders Noren — Up ↑